Comments
Bayer wins early U.S. approval for colon cancer drug
28.09.2012. | (Reuters) - The U.S. Food and Drug Administration on Thursday approved a new drug for advanced colon cancer developed by Bayer AG, a month ahead of the agency's expected action date for a decision....
